Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001393905-21-000352
Filing Date
2021-08-05
Accepted
2021-08-05 10:52:29
Documents
1
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2054
  Complete submission text file 0001393905-21-000352.txt   3623
Mailing Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001
Business Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001 800-497-6059
Rapid Therapeutic Science Laboratories, Inc. (Issuer) CIK: 0001575659 (see all company filings)

EIN.: 462111820 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 639 SWORD BRIDGE DR. LEWISVILLE TX 75056
Business Address
Justin Scott Suggs (Reporting) CIK: 0001876984 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55018 | Film No.: 211146931